MedTrace Logo

Effects of Adherence Therapy on Medication Adherence in Patients With Schizophrenia Spectrum Disorder

NCT04022577 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2024-03-07

No results posted yet for this study

Summary

This study will explore the effect of Adherence Therapy(AT) on medication adherence in patients with schizophrenia spectrum disorder.

Conditions

  • Motivational Interviewing
  • Schizophrenia Spectrum Disorder
  • Medication Adherence

Interventions

BEHAVIORAL

Adherence Therapy

Motivational interviewing-based AT in this study was based on Chien et al., (2016) and Gray et al., (2010) eight-session AT using the motivational interviewing technique (and principles of cognitive behavioral therapy).

BEHAVIORAL

control group

The control group received routine care

Sponsors & Collaborators

  • Taipei Veterans General Hospital, Taiwan

    collaborator OTHER_GOV

  • National Yang Ming Chiao Tung University

    lead OTHER

Principal Investigators

  • Yan Laing Chen, BSN · Institute of Community Health Care National Yang-Ming University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-01
Primary Completion
2019-08-30
Completion
2019-09-30

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04022577 on ClinicalTrials.gov